Anavex Life Sciences Corp (AVXL)

[Reyeton]

That’s a lot of shares. I cannot totally believe Missling is as corrupt as he sometimes appears to be. Lack of transparency, missed deadlines and a seeming lack of ability to capture the talent of those he surrounds himself with certainly doesn’t add credibility to his resume. But, with that being said, there does seem to be changes happening in the FDA that could boost our chances of approval in the not too distant future. Rett and AD are still on the table, according to Missling. If they somehow find a way to cross the finish line with A2-73, 50 bucks per share will look like pocket change. All my personal opinion, fwiw, so don’t take it as investment advice. Maybe Missling will taper his ego a bit and let the professionals around him do their job.